Immune Thrombocytopenia: Why Every Patient Voice Matters @Novartis
Immune Thrombocytopenia: Why Every Patient Voice Matters  @Novartis
Uploaded September 2026 | Updated November 2026, 1 day ago
Immune thrombocytopenia (ITP) is more than a platelet count.

In this video, patient advocates and physicians share their perspectives on living with ITP, the importance of understanding each person's individual experience, and how meaningful conversations can help support patient-centred care.

Featuring Danielle Boyle (ITP Australia & New Zealand), Barbara Lovrencic (AIPIT, Italian ITP Patient Association), Dr. Charlotte Bradbury (University of Bristol) and Dr. Francesco Zaja (Maggiore Hospital Trieste), this discussion highlights the value of looking beyond laboratory values to understand what matters most to people living with ITP.

Insights presented in this video are supported by findings from the I-WISh 2.0 study1.

Reference:
1 N. Cooper, J. Bussel, W. Ghanima, et al., “ Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0,” American Journal of Hematology 101, no. 8 (2026): 1954–1968, https://novartis.social/6050azc64.

©2026 Novartis AG
Immune Thrombocytopenia: Why Every Patient Voice MattersViaOpta SimImagine if you could switch jobs with anyoneLiving with neuroendocrine cancer – meet Rachael30 years of Novartis, powered by 250 years of innovationNext Generation Scientist 2023ISGlobal and Novartis: Co-creating solutions for people affected by Chagas diseaseCelebrating Our Unique Talents Through Music - Gustavo’s storyStrategic Value for ShareholdersSickle cell disease screening a critical step to save lives and improve careDriving the next generation of CAR-T therapyNext Generation Scientist 2023
Novartis |

Immune Thrombocytopenia: Why Every Patient Voice Matters

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER